NGSベースRNAシーケンシングの世界市場予測:サンプル準備、プラットフォーム&消耗品、サービス、データ分析

MarketsandMarketsが発行した調査報告書(BT 5297)
◆英語タイトル:NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
◆商品コード:BT 5297
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2019年9月27日
◆ページ数:157
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、NGSベースRNAシーケンシングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品&サービス別(サンプル準備、プラットフォーム&消耗品、サービス、データ分析)分析、技術別(SBS、SMRT、Nanopore)分析、用途別(De Novo、エピジェネティクス、small RNA)分析、エンドユーザー別分析、NGSベースRNAシーケンシングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、NGSベースRNAシーケンシングの世界市場規模が2019年17億ドルから2024年42億ドルまで年平均20.0%成長すると予測しています。

・イントロダクション・エグゼクティブサマリー
・NGSベースRNAシーケンシングの世界市場:市場インサイト
・NGSベースRNAシーケンシングの世界市場:市場概観/市場動向
・NGSベースRNAシーケンシングの世界市場:市場シェア分析
・NGSベースRNAシーケンシングの世界市場:製品&サービス別(サンプル準備、プラットフォーム&消耗品、サービス、データ分析)分析/市場規模
・NGSベースRNAシーケンシングの世界市場:技術別(SBS、SMRT、Nanopore)分析/市場規模
・NGSベースRNAシーケンシングの世界市場:用途別(De Novo、エピジェネティクス、small RNA)分析/市場規模
・NGSベースRNAシーケンシングの世界市場:エンドユーザー別分析/市場規模
・NGSベースRNAシーケンシングのアジア市場規模予測
・NGSベースRNAシーケンシングのヨーロッパ市場規模予測
・NGSベースRNAシーケンシングのアメリカ市場規模予測
・NGSベースRNAシーケンシングの世界市場動向
・NGSベースRNAシーケンシングの世界市場:競争状況
・NGSベースRNAシーケンシングの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.”
The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA sequencing industry.

“Pharmaceutical & biotechnology companies segment to witness the highest growth in the NGS-based RNA-sequencing market during the forecast period.”
Based on the end-user, the NGS-based RNA-sequencing industry is segmented into research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness highest growth rate during the forecast period mainly due to growing number of agreements and collaborations between NGS market players and pharmaceutical & biotechnology companies for the development of advanced products.

“Expression profiling analysis application to hold the largest share in the NGS-based RNA-sequencing market.”
Based on application, the NGS-based market is segmented into expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share mainly due to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases will propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

“The Asia Pacific market is expected to witness the highest CAGR during the forecast period.”
The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
• By Designation: C-level: 47%, D-level: 33%, and Others: 20%
• By Region: North America: 35%, Europe: 32%, APAC: 25%, Latin America: 6% and Middle East & Africa: 2%

The major players operating in the NGS-based RNA-sequencing market are Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market

Research Coverage
This report studies the NGS-based RNA-sequencing market based on product & service, technology, application, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (and the respective countries in these regions).

Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis—market ranking analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the NGS-based RNA-sequencing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.2 Market Estimation Methodology
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
4.1 NGS-Based RNA-Sequencing: Market Overview
4.2 NGS-Based RNA-Sequencing Market, By Product & Service, 2019 vs. 2024 (USD Million)
4.3 NGS-Based RNA-Sequencing Market Share, By Technology, 2019 vs. 2024
4.4 NGS-Based RNA-Sequencing Market, By Application, 2019 vs. 2024 (USD Million)
4.5 NGS-Based RNA-Sequencing Market Share, By End User, 2019 vs. 2024
4.6 Geographical Snapshot of the NGS-Based RNA-Sequencing Market
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advantages of RNA-Seq Over Conventional Technologies
5.2.1.2 Increasing Number of RNA-Seq Grants
5.2.1.3 Growing Number of Research Activities Involving RNA-Seq
5.2.1.4 Rapid Growth in Precision Medicine
5.2.2 Restraints
5.2.2.1 Lack of Skilled Professionals
5.2.2.2 Standardization Concerns of RNA-Seq in Diagnostic Testing
5.2.3 Opportunities
5.2.3.1 Increasing Applications of RNA-Seq in Research
5.2.3.1.1 Cancer Research
5.2.3.1.2 Agricultural Research
5.2.4 Challenges
5.2.4.1 Storage & Interpretation of Sequencing Data
5.2.4.2 Analysis of RNA-Seq Data for the Detection of Novel Transcripts
6 NGS-Based RNA-Sequencing Market, By Product & Service (Page No. – 41)
6.1 Introduction
6.2 RNA Sequencing Platforms & Consumables
6.2.1 Increasing Availability of Platforms and Growing Consumable Usage Have Ensured the High Share of This Segment
6.3 Sample Preparation Products
6.3.1 Sample Preparation is the First Step of an NGS Workflow
6.3.2 Sample Preparation Products, By Workflow
6.3.2.1 Library Preparation & Target Enrichment
6.3.2.2 Quality Control
6.3.3 Sample Preparation Products, By Method
6.3.3.1 Manual Sample Preparation
6.3.3.2 Microfluidic Sample Preparation
6.3.3.3 Robotic Liquid Handling Sample Preparation
6.4 RNA Sequencing Services
6.4.1 Lack of Infrastructure and Expertise Among End Users has Driven Demand for Services
6.5 Data Analysis, Storage & Management
6.5.1 Integration of Cloud Computing and Bioinformatics, Among Other Advancements, is Contributing to Market Growth
7 NGS-Based RNA-Sequencing Market, By Technology (Page No. – 48)
7.1 Introduction
7.2 Sequencing By Synthesis
7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time
7.3 Ion Semiconductor Sequencing
7.3.1 Ion Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
7.4 Single-Molecule Real-Time Sequencing
7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct RNA-Sequencing Capabilities
8 NGS-Based RNA-Sequencing Market, By Application (Page No. – 54)
8.1 Introduction
8.2 Expression Profiling Analysis
8.2.1 Increasing Need for Improved Prognosis of Patients to Propel Market Growth
8.3 Small RNA Sequencing
8.3.1 Rising Need for Accurate Diagnostic Analysis to Support Market Growth
8.4 De Novo Transcriptome Assembly
8.4.1 Increasing Cancer Cases is Expected to Drive This Application Segment
8.5 Variant Calling & Transcriptome Epigenetics
8.5.1 Complicated RNA-Seq Data Analysis May Hamper the Growth of This Segment
9 NGS-Based RNA-Sequencing Market, By End User (Page No. – 60)
9.1 Introduction
9.2 Research & Academia
9.2.1 Increasing Number of Collaborations Between NGS Market Players and Academic & Research Institutes to Propel Market Growth
9.3 Hospitals & Clinics
9.3.1 Increasing Adoption of NGS Systems in Hospitals & Clinics to Drive Market Growth
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Consolidation Between Biotech & Pharma Companies and NGS Market Players to Propel Market Growth
9.5 Other End Users
10 NGS-Based RNA-Sequencing Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Favorable Funding Scenario and Growing R&D Activity in the US are Driving Market Growth
10.2.2 Canada
10.2.2.1 Government Initiatives for Genome Research Will Boost the Adoption of NGS Sequencing Technology
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominates the NGS-Based RNA-Sequencing Market in Europe
10.3.2 UK
10.3.2.1 Strong Presence of NGS Organizations and Supportive Initiatives Will Drive Market Growth in the UK
10.3.3 France
10.3.3.1 Growing Awareness on Applications of High-Throughput Sequencing in Genetic Characterization Will Support Market Growth
10.3.4 RoE
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Strong Base of Established Players and Favorable Government Initiatives Account for China’s Large Market Share
10.4.2 Japan
10.4.2.1 Growing Awareness and Rising Incidence of Genetic Disorders are Driving Demand for NGS-Based RNA-Seq in Japan
10.4.3 India
10.4.3.1 Rising Awareness and Player Interest in India Will Drive Market Growth
10.4.4 RoAPAC
10.5 Latin America
10.5.1 Brazil
10.5.1.1 High Hiv Prevalence in Brazil has Driven Demand for NGS in Research
10.5.2 Mexico
10.5.2.1 Economic Growth and Support for Infrastructural Development Will Drive Market Growth in Mexico
10.5.3 RoLA
10.6 Middle East & Africa
10.6.1 Lack of Infrastructure has Stifled Market Growth in the MEA
11 Competitive Landscape (Page No. – 101)
11.1 Introduction
11.2 Competitive Leadership Mapping
11.2.1 Terminology/Nomenclature
11.2.1.1 Visionary Leaders
11.2.1.2 Innovators
11.2.1.3 Dynamic Differentiators
11.2.1.4 Emerging Companies
11.3 Competitive Scenario (2015-2019)
11.4 NGS-Based RNA-Sequencing Market Ranking, By Top Three Market Players (2018)
12 Company Profiles (Page No. – 109)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Agilent Technologies
12.2 BGI Group
12.3 Eurofins Scientific
12.4 GENEWIZ (Part of Brooks Automation)
12.5 Hamilton Company
12.6 Illumina
12.7 Nugen Technologies (Part of Tecan Trading AG)
12.8 Oxford Nanopore Technologies
12.9 Perkinelmer
12.10 Psomagen
12.11 QIAGEN
12.12 F. Hoffmann-La Roche AG
12.13 Takara Bio
12.14 Thermo Fisher Scientific
12.15 Zymo Research
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 148)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (87 Tables)
Table 1 NGS-Based RNA-Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 2 RNA Sequencing Platforms & Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Sample Preparation Products Market, By Region, 2017–2024 (USD Million)
Table 4 RNA Sequencing Services Market, By Region, 2017–2024 (USD Million)
Table 5 Data Analysis, Storage & Management Market, By Region, 2017–2024 (USD Million)
Table 6 NGS-Based RNA-Sequencing Market, By Technology, 2017–2024 (USD Million)
Table 7 Sequencing By Synthesis Market, By Region, 2017–2024 (USD Million)
Table 8 Ion Semiconductor Sequencing Market, By Region, 2017–2024 (USD Million)
Table 9 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2024 (USD Million)
Table 10 Nanopore Sequencing Market, By Region, 2017–2024 (USD Million)
Table 11 NGS-Based RNA-Sequencing Market, By Application, 2017–2024 (USD Million)
Table 12 Expression Profiling Analysis Market, By Region, 2017–2024 (USD Million)
Table 13 Small RNA Sequencing Market, By Region, 2017–2024 (USD Million)
Table 14 De Novo Transcriptome Assembly Market, By Region, 2017–2024 (USD Million)
Table 15 Variant Calling & Transcriptome Epigenetics Market, By Region, 2017–2024 (USD Million)
Table 16 NGS-Based RNA-Sequencing Market, By End User, 2017–2024 (USD Million)
Table 17 NGS-Based RNA-Sequencing Market for Research & Academia, By Region, 2017–2024 (USD Million)
Table 18 NGS-Based RNA-Sequencing Market for Hospitals & Clinics, By Region, 2017–2024 (USD Million)
Table 19 NGS-Based RNA-Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 20 NGS-Based RNA-Sequencing Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 21 NGS-Based RNA-Seq Market, By Region, 2017-2024 (USD Million)
Table 22 North America: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 23 North America: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 24 North America: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 25 North America: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 26 North America: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 27 US: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 28 US: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 29 US: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 30 Canada: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 31 Canada: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 32 Canada: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 33 Europe: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 34 Europe: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 35 Europe: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 36 Europe: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 37 Europe: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 38 Germany: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 39 Germany: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 40 Germany: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 41 UK: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 42 UK: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 43 UK: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 44 France: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 45 France: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 46 France: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 47 RoE: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 48 RoE: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 49 RoE: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 50 Asia Pacific: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 51 Asia Pacific: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 52 Asia Pacific: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 53 Asia Pacific: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 54 Asia Pacific: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 55 China: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 56 China: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 57 China: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 58 Japan: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 59 Japan: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 60 Japan: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 61 India: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 62 India: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 63 India: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 64 RoAPAC: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 65 RoAPAC: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 66 RoAPAC: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 67 Latin America: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 68 Latin America: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Latin America: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 70 Latin America: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 71 Latin America: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 72 Brazil: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 73 Brazil: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 74 Brazil: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 75 Mexico: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 76 Mexico: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 77 Mexico: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 78 RoLA: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 79 RoLA: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 80 RoLA: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 81 MEA: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 82 MEA: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 83 MEA: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 84 MEA: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 85 New Product Launches
Table 86 Acquisitions
Table 87 Partnerships, Agreements, and Collaborations

List of Figures (38 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primaries
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Product-Based Market Estimation: NGS-Based RNA-Sequencing Market
Figure 5 Application-Based Market Estimation: NGS-Based RNA-Sequencing Market
Figure 6 Data Triangulation
Figure 7 Assumptions of the Research Study
Figure 8 NGS-Based RNA-Sequencing Market, By Product & Service, 2019 vs. 2024 (USD Million)
Figure 9 NGS-Based RNA-Sequencing Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 10 NGS-Based RNA-Sequencing Market Share, By Application, 2019 vs. 2024
Figure 11 NGS-Based RNA-Sequencing Market, By End User, 2019 vs. 2024 (USD Million)
Figure 12 NGS-Based RNA-Sequencing Market: Geographic Growth Opportunities
Figure 13 Increasing Number of Research Activities Involving RNA-Seq & Rapid Growth in Precision Medicine to Drive Market Growth
Figure 14 RNA Sequencing Platforms & Consumables to Dominate the NGS-Based RNA-Sequencing Market During the Forecast Period
Figure 15 Sequencing By Synthesis Segment Will Continue to Dominate the NGS-Based RNA-Sequencing Market in 2024
Figure 16 Expression Profiling Analysis Segment Dominates the NGS-Based RNA-Sequencing Applications Market
Figure 17 Research & Academia are the Largest End Users of NGS-Based RNA-Sequencing
Figure 18 China is the Fastest-Growing Country in the NGS-Based RNA-Sequencing Market
Figure 19 NGS-Based RNA-Sequencing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Global Funding Activities for RNA-Seq and Microarray Projects, 2009–2016
Figure 21 Number of RNA-Seq Publications Globally, 2008–2016
Figure 22 North America: NGS-Based RNA-Seq Market Snapshot
Figure 23 Europe: NGS-Based RNA-Seq Market Snapshot
Figure 24 Asia Pacific: NGS-Based RNA-Seq Market Snapshot
Figure 25 NGS-Based RNA-Sequencing Market, Competitive Leadership Mapping, 2018 (Overall Market)
Figure 26 NGS Based RNA-Sequencing Market, Competitive Leadership Mapping, 2018 (SME/Start-Ups)
Figure 27 Key Developments in the NGS Based RNA-Sequencing Market, 2016–2019
Figure 28 Illumina Held the Leading Position in the NGS Based RNA-Sequencing Market as of 2018
Figure 29 Agilent Technologies: Company Snapshot (2018)
Figure 30 Eurofins: Company Snapshot (2018)
Figure 31 Brooks Automation, Inc.: Company Snapshot (2018)
Figure 32 Illumina: Company Snapshot (2018)
Figure 33 Tecan: Company Snapshot (2018)
Figure 34 Perkin Elmer: Company Snapshot (2018)
Figure 35 QIAGEN: Company Snapshot (2018)
Figure 36 Roche: Company Snapshot (2018)
Figure 37 Takara Bio: Company Snapshot (2017)
Figure 38 Thermo Fischer: Company Snapshot (2018)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ NGSベースRNAシーケンシングの世界市場予測:サンプル準備、プラットフォーム&消耗品、サービス、データ分析(NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆